To date, CEPI has established multiple partnership agreements, reflecting a potential investment of over $270 million. Through these collaborations, we're supporting the development of a wide range of vaccine candidates.
We also have number of additional partnerships under negotiation. These partnership agreements represent the start of CEPI’s product development portfolio. See below current details of our vaccine portfolio.